{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:15:44Z","timestamp":1789474544159,"version":"build-2803163510"},"reference-count":344,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1800800"],"award-info":[{"award-number":["2023YFD1800800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1802200"],"award-info":[{"award-number":["2023YFD1802200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171931"],"award-info":[{"award-number":["32171931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20518"],"award-info":[{"award-number":["U22A20518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The hazards posed by viral infections are becoming increasingly severe. The expanding infected population, surging risks of outbreaks, and heightened immune evasion demand continuous structural innovation in antiviral chemical agents beyond vaccines. Macrocyclic structures have achieved remarkable success in combating HCV, drawing growing attention to their potential in antiviral applications. FDA-approved macrocyclic drugs are now being widely explored for their feasibility in broader antiviral therapies. These macrocyclic compounds employ a distinctive mechanism to effectively target multiple stages of the viral life cycle. Its unique structure endows it with greater potential as an antiviral target and better druggability. By virtue of their structural advantages, they constrain viral immune evasion and demonstrate remarkable efficacy in addressing critical clinical challenges, particularly in counteracting drug resistance. Herein, we summarize antiviral macrocyclic drugs studied over the past decade, examining their structural advantages, structure\u2013activity relationships, and molecular mechanisms from both viral and host perspectives during the viral lifecycle.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02430","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:11:49Z","timestamp":1760098309000},"page":"21035-21071","source":"Crossref","is-referenced-by-count":6,"title":["Macrocyclic\nCompounds: Unveiling Their Distinctive\nAntiviral Advantages in Medicinal Research"],"prefix":"10.1021","volume":"68","author":[{"given":"Xiaopei","family":"Yang","sequence":"first","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai University of Traditional Chinese Medicine , , No.1200, Cailun Road , ,","place":["Shanghai, China, 201203"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]},{"name":"State Key Laboratory of Integration and Innovation of Classical Formula and Modern Chinese Medicine , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Jiao","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangchuang","family":"Fan","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchong","family":"Ye","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Lv","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7328-7354","authenticated-orcid":true,"given":"Xisong","family":"Ke","sequence":"additional","affiliation":[{"name":"Shanghai University of Traditional Chinese Medicine , , No.1200, Cailun Road , ,","place":["Shanghai, China, 201203"]},{"name":"State Key Laboratory of Integration and Innovation of Classical Formula and Modern Chinese Medicine , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3961-1816","authenticated-orcid":true,"given":"Wen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , ,","place":["Shanghai, China, 200241"]},{"name":"Shanghai Research Institute, Chinese Academy of Agricultural Sciences , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"7","key":"2026072715541688200_cit1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/17460441.2020.1751117","article-title":"The emerging\nrole of computational design in peptide macrocycle drug discovery","volume":"15","author":"Mulligan","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"2026072715541688200_cit2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9504-2_1","article-title":"Design\nPrinciples for Intestinal Permeability of Cyclic Peptides","volume":"2001","author":"Mathiowetz","year":"2019","journal-title":"Cyclic Peptide Design"},{"issue":"1","key":"2026072715541688200_cit3","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400890","article-title":"FDA-approved drugs\nfeaturing macrocycles or medium-sized rings","volume":"358","author":"Du","year":"2025","journal-title":"Arch Pharm. (Weinheim)"},{"issue":"8","key":"2026072715541688200_cit4","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1021\/acs.nanolett.4c06362","article-title":"Small Molecule\nDrugs Triggered the Activation of Macrocycle Masked Proteins","volume":"25","author":"Zeng","year":"2025","journal-title":"Nano Lett."},{"issue":"12","key":"2026072715541688200_cit5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/d41573-023-00171-0","article-title":"FDA approves\nC5-blocking macrocyclic peptide for autoimmune disease","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov"},{"issue":"8","key":"2026072715541688200_cit6","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1021\/acs.jmedchem.3c00134","article-title":"Macrocycles in Drug\nDiscovery horizontal line Learning from the Past for the Future","volume":"66","author":"Garcia Jimenez","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026072715541688200_cit7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/chem.201902716","article-title":"Drug Syntheses\nBeyond the Rule of 5","volume":"26","author":"Tyagi","year":"2020","journal-title":"Chemistry"},{"issue":"22","key":"2026072715541688200_cit8","doi-asserted-by":"publisher","first-page":"20258","DOI":"10.1021\/acs.jmedchem.4c01639","article-title":"De Novo Discovery of\na Noncovalent Cell-Penetrating Bicyclic Peptide\nInhibitor Targeting SARS-CoV-2 Main Protease","volume":"67","author":"Tan","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026072715541688200_cit9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbrc.2021.10.009","article-title":"Human hepatitis\nB virus-derived virus-like\nparticle as a drug and DNA delivery carrier","volume":"581","author":"Sakai","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"2026072715541688200_cit10","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1021\/acs.molpharmaceut.9b00180","article-title":"Lung Tissue Delivery of Virus-Like\nParticles Mediated\nby Macrolide Antibiotics","volume":"16","author":"Crooke","year":"2019","journal-title":"Mol. Pharmaceutics"},{"issue":"40","key":"2026072715541688200_cit11","doi-asserted-by":"publisher","first-page":"12746","DOI":"10.1021\/acs.jafc.2c04822","article-title":"Supramolecular Biopharmaceutical\nCarriers Based on Host-Guest Interactions","volume":"70","author":"Li","year":"2022","journal-title":"J.\nAgric. Food Chem."},{"key":"2026072715541688200_cit12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3389\/fimmu.2019.01366","article-title":"Peptide Antiviral\nStrategies as an Alternative to Treat Lower Respiratory Viral Infections","volume":"10","author":"Nyanguile","year":"2019","journal-title":"Front Immunol"},{"issue":"10","key":"2026072715541688200_cit13","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.bmc.2017.08.006","article-title":"Advances in macrocyclic peptide-based\nantibiotics","volume":"26","author":"Luther","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"2026072715541688200_cit14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.992171","article-title":"Utilization of macrocyclic peptides to target protein-protein\ninteractions in cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"issue":"9","key":"2026072715541688200_cit15","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/cells9092100","article-title":"Ivermectin as a\nBroad-Spectrum Host-Directed Antiviral:\nThe Real Deal?","volume":"9","author":"Jans","year":"2020","journal-title":"Cells"},{"issue":"3","key":"2026072715541688200_cit16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jhep.2019.04.017","article-title":"Sustained\nvirologic response to direct-acting antiviral\ntherapy in patients with chronic hepatitis C and hepatocellular carcinoma:\nA systematic review and meta-analysis","volume":"71","author":"Ji","year":"2019","journal-title":"J. Hepatol"},{"issue":"10","key":"2026072715541688200_cit17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40262-023-01302-x","article-title":"Mechanisms\nand Clinical Significance of Pharmacokinetic Drug Interactions Mediated\nby FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents","volume":"62","author":"Murray","year":"2023","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2026072715541688200_cit18","doi-asserted-by":"publisher","first-page":"e910","DOI":"10.1093\/cid\/ciac585","article-title":"Decreased Dolutegravir and Efavirenz Concentrations\nWith Preserved Virological Suppression in Patients With Tuberculosis\nand Human Immunodeficiency Virus Receiving High-Dose Rifampicin","volume":"76","author":"Sekaggya-Wiltshire","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026072715541688200_cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112739","article-title":"Azithromycin:\nThe First Broad-spectrum Therapeutic","volume":"207","author":"Firth","year":"2020","journal-title":"Eur. J.\nMed. Chem."},{"issue":"1","key":"2026072715541688200_cit20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","article-title":"Global\nInitiative for the Diagnosis, Management, and Prevention of Chronic\nObstructive Lung Disease. The 2020 GOLD Science Committee Report on\nCOVID-19 and Chronic Obstructive Pulmonary Disease","volume":"203","author":"Halpin","year":"2021","journal-title":"Am. J. Respir Crit Care Med."},{"issue":"6","key":"2026072715541688200_cit21","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining\nand managing\nCOVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus\ncriteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2026072715541688200_cit22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.tim.2019.01.001","article-title":"Hepatitis C Virus","volume":"27","author":"Pietschmann","year":"2019","journal-title":"Trends Microbiol"},{"key":"2026072715541688200_cit23","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis\nC virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat. Rev. Dis Primers"},{"issue":"2","key":"2026072715541688200_cit24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1021\/acs.jmedchem.3c01971","article-title":"Hepatitis\nC: The Story of a Long\nJourney through First, Second, and Third Generation NS3\/4A Peptidomimetic\nInhibitors. What Did We Learn?","volume":"67","author":"Martino","year":"2024","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026072715541688200_cit25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/advances\/nmab128","article-title":"The Role of\nImmunomodulatory Nutrients in Alleviating Complications Related to\nSARS-CoV-2: A Scoping Review","volume":"13","author":"Jandaghi","year":"2022","journal-title":"Adv. Nutr"},{"issue":"3","key":"2026072715541688200_cit26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.102962","article-title":"Residues\nE53, L55, H59, and G70 of the cellular receptor\nprotein Tva mediate cell binding and entry of the novel subgroup K\navian leukosis virus","volume":"299","author":"Li","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"3","key":"2026072715541688200_cit27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/nutrit\/nuab092","article-title":"The role of vitamin B12 in viral\ninfections: a comprehensive review of its relationship with the muscle-gut-brain\naxis and implications for SARS-CoV-2 infection","volume":"80","author":"Batista","year":"2022","journal-title":"Nutr. Rev."},{"issue":"18","key":"2026072715541688200_cit28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00678-22","article-title":"Residues L55 and W69 of Tva Mediate Entry of\nSubgroup\nA Avian Leukosis Virus","volume":"96","author":"Chen","year":"2022","journal-title":"J. Virol"},{"issue":"10","key":"2026072715541688200_cit29","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.3390\/ijms24108765","article-title":"Novel\nPolymyxin-Inspired Peptidomimetics Targeting\nthe SARS-CoV-2 Spike:hACE2 Interface","volume":"24","author":"Bugatti","year":"2023","journal-title":"Int. J.\nMol. Sci."},{"issue":"4","key":"2026072715541688200_cit30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007625","article-title":"Dengue virus nonstructural protein\n1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia\nand hemorrhage","volume":"15","author":"Chao","year":"2019","journal-title":"PLoS Pathog"},{"issue":"17","key":"2026072715541688200_cit31","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1111\/febs.15369","article-title":"Understanding\nSARS-CoV-2 endocytosis for COVID-19 drug repurposing","volume":"287","author":"Glebov","year":"2020","journal-title":"FEBS J."},{"key":"2026072715541688200_cit32","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00519-25","article-title":"SARS-CoV-2\ninfection enhancement by amphotericin\nB: implications for disease management","volume":"99","author":"Nguyen","year":"2025","journal-title":"J. Virol"},{"issue":"18","key":"2026072715541688200_cit33","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic Treatments\nfor Coronavirus Disease 2019 (COVID-19): A Review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"2026072715541688200_cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117437","article-title":"Macrolide resistance outcomes after the Covid-19 pandemic:\nA one health approach investigation","volume":"180","author":"Rodrigues","year":"2024","journal-title":"Biomed\nPharmacother"},{"issue":"11","key":"2026072715541688200_cit35","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.3390\/microorganisms11112777","article-title":"Potent Antiviral Activity of Vitamin B12 against\nSevere Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory\nSyndrome Coronavirus, and Human Coronavirus 229E","volume":"11","author":"Moatasim","year":"2023","journal-title":"Microorganisms"},{"issue":"8","key":"2026072715541688200_cit36","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/v13081537","article-title":"Active Components of Commonly Prescribed\nMedicines Affect Influenza A Virus-Host Cell Interaction: A Pilot\nStudy","volume":"13","author":"Ianevski","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"2026072715541688200_cit37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/biology9080192","article-title":"The Antiviral\nProperties of Cyclosporine. Focus on\nCoronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency\nVirus Infections","volume":"9","author":"Glowacka","year":"2020","journal-title":"Biology (Basel)"},{"issue":"12","key":"2026072715541688200_cit38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/ph14121227","article-title":"Teicoplanin-A\nNew Use for an Old Drug in the COVID-19 Era?","volume":"14","author":"Vimberg","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"13","key":"2026072715541688200_cit39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-Immunomodulatory Therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"issue":"12","key":"2026072715541688200_cit40","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s40262-019-00806-9","article-title":"Clinical Pharmacodynamics,\nPharmacokinetics, and Drug Interaction Profile of Doravirine","volume":"58","author":"Boyle","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"2026072715541688200_cit41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.gastro.2021.01.223","article-title":"Tacrolimus Use and COVID-19 Infection\nin Patients After Solid Organ Transplantation","volume":"161","author":"Yin","year":"2021","journal-title":"Gastroenterology"},{"issue":"7","key":"2026072715541688200_cit42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2201662","article-title":"Randomized\nTrial of\nMetformin, Ivermectin, and Fluvoxamine for Covid-19","volume":"387","author":"Bramante","year":"2022","journal-title":"N Engl J. Med."},{"key":"2026072715541688200_cit43","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104808","article-title":"Alphavirus capsid protease\ninhibitors as potential antiviral agents for Chikungunya infection","volume":"179","author":"Fatma","year":"2020","journal-title":"Antiviral Res."},{"issue":"1","key":"2026072715541688200_cit44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/22221751.2022.2049983","article-title":"Rifapentine\nis an entry and replication inhibitor against yellow fever virus both\nin vitro and in vivo","volume":"11","author":"Qian","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"2026072715541688200_cit45","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/cid\/ciab1037","article-title":"Efavirenz\nPharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral\nSuppression Among Patients Receiving Tuberculosis Treatment Containing\nDaily High-Dose Rifapentine","volume":"75","author":"Podany","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2026072715541688200_cit46","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1093\/cid\/ciac707","article-title":"Rifapentine With and Without Moxifloxacin for Pulmonary\nTuberculosis in People With Human Immunodeficiency Virus (S31\/A5349)","volume":"76","author":"Pettit","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2026072715541688200_cit47","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/infdis\/jiaa071","article-title":"Sirolimus and Other Mechanistic Target of Rapamycin\nInhibitors Directly Activate Latent Pathogenic Human Polyomavirus\nReplication","volume":"224","author":"Alvarez Orellana","year":"2021","journal-title":"J. Infect Dis"},{"issue":"9","key":"2026072715541688200_cit48","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.scib.2020.12.005","article-title":"Protoporphyrin IX and verteporfin potently\ninhibit SARS-CoV-2 infection\nin vitro and in a mouse model expressing human ACE2","volume":"66","author":"Gu","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"issue":"4","key":"2026072715541688200_cit49","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/ph14040338","article-title":"Micafungin Inhibits\nDengue Virus Infection through the Disruption\nof Virus Binding, Entry, and Stability","volume":"14","author":"Chen","year":"2021","journal-title":"Pharmaceuticals\n(Basel)"},{"issue":"1","key":"2026072715541688200_cit50","doi-asserted-by":"publisher","first-page":"13303","DOI":"10.1038\/s41598-024-61127-x","article-title":"Antiviral\nactivity of pimecrolimus against dengue virus type 2 infection in\nvitro and in vivo","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep"},{"issue":"11","key":"2026072715541688200_cit51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009022","article-title":"Calcineurin phosphatase\nactivity regulates Varicella-Zoster Virus induced cell-cell fusion","volume":"16","author":"Zhou","year":"2020","journal-title":"PLoS Pathog"},{"key":"2026072715541688200_cit52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.antiviral.2018.10.005","article-title":"Micafungin is a\nnovel anti-viral agent of chikungunya virus through\nmultiple mechanisms","volume":"159","author":"Ho","year":"2018","journal-title":"Antiviral Res."},{"issue":"2","key":"2026072715541688200_cit53","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/v15020452","article-title":"Antiviral\nActivity of Micafungin\nand Its Derivatives against SARS-CoV-2 RNA Replication","volume":"15","author":"Nakajima","year":"2023","journal-title":"Viruses"},{"key":"2026072715541688200_cit54","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1080\/07391102.2024.2309643","article-title":"The in vitro and in vivo antiviral effects of IGF1R\ninhibitors against respiratory syncytial virus infection","volume":"43","author":"Ruan","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"2026072715541688200_cit55","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105188","article-title":"Synergistic\nin-vitro antiviral effects of combination treatment using anidulafungin\nand T-1105 against Zika virus infection","volume":"195","author":"Lu","year":"2021","journal-title":"Antiviral\nRes."},{"issue":"34","key":"2026072715541688200_cit56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203088","article-title":"SRSF5-Mediated Alternative Splicing of M Gene\nis Essential\nfor Influenza A Virus Replication: A Host-Directed Target Against\nInfluenza Virus","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"24","key":"2026072715541688200_cit57","doi-asserted-by":"publisher","first-page":"14067","DOI":"10.1080\/07391102.2021.2000498","article-title":"Suramin, penciclovir,\nand anidulafungin exhibit potential in the treatment of COVID-19 via\nbinding to nsp12 of SARS-CoV-2","volume":"40","author":"Dey","year":"2022","journal-title":"J. Biomol Struct\nDyn"},{"issue":"8","key":"2026072715541688200_cit58","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3390\/v14081827","article-title":"Pharmacophore-Model-Based\nDrug Repurposing for the Identification of the Potential Inhibitors\nTargeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA\nPolymerase","volume":"14","author":"Kumar","year":"2022","journal-title":"Viruses"},{"issue":"24","key":"2026072715541688200_cit59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160766","article-title":"Rapalogs\ndownmodulate intrinsic immunity and promote\ncell entry of SARS-CoV-2","volume":"132","author":"Shi","year":"2022","journal-title":"J. Clin. Invest."},{"key":"2026072715541688200_cit60","doi-asserted-by":"publisher","first-page":"1118801","DOI":"10.3389\/fcimb.2023.1118801","article-title":"Plerixafor\nand resatorvid inhibit hepatitis B virus in vitro by upregulating\nelongation factor Tu GTP-binding domain containing 2","volume":"13","author":"Cai","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2026072715541688200_cit61","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/v14081750","article-title":"Searching for Blockers of Dengue\nand West Nile Virus\nViroporins","volume":"14","author":"Lahiri","year":"2022","journal-title":"Viruses"},{"issue":"11","key":"2026072715541688200_cit62","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","article-title":"Early\nintervention with 3BNC117 and romidepsin\nat antiretroviral treatment initiation in people with HIV-1: a phase\n1b\/2a, randomized trial","volume":"28","author":"Gunst","year":"2022","journal-title":"Nat. Med."},{"key":"2026072715541688200_cit63","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105456","article-title":"Everolimus\nreduces BK polyomavirus infection by suppressing its replication and\nspread of infection","volume":"208","author":"Sato","year":"2022","journal-title":"Antiviral Res."},{"issue":"1","key":"2026072715541688200_cit64","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12916-020-01663-1","article-title":"Antibiotic fidaxomicin is an RdRp inhibitor\nas a potential new therapeutic\nagent against Zika virus","volume":"18","author":"Yuan","year":"2020","journal-title":"BMC Med."},{"key":"2026072715541688200_cit65","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.642313","article-title":"Management of SARS-CoV-2 Infection: Key Focus\nin Macrolides Efficacy for COVID-19","volume":"8","author":"Batiha","year":"2021","journal-title":"Front Med.\n(Lausanne)"},{"key":"2026072715541688200_cit66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2018.04.016","article-title":"Novel activities of\nsafe-in-human broad-spectrum antiviral agents","volume":"154","author":"Ianevski","year":"2018","journal-title":"Antiviral Res."},{"issue":"17","key":"2026072715541688200_cit67","doi-asserted-by":"publisher","first-page":"9218","DOI":"10.1074\/jbc.M116.716100","article-title":"Glycopeptide Antibiotics\nPotently Inhibit Cathepsin L in the Late\nEndosome\/Lysosome and Block the Entry of Ebola Virus, Middle East\nRespiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory\nSyndrome Coronavirus (SARS-CoV)","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026072715541688200_cit68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/cid\/ciae269","article-title":"Effectiveness of Double-Dose Dolutegravir in People\nReceiving Rifampin-based Tuberculosis Treatment: An Observational,\nCohort Study of People With Human Immunodeficiency Virus From 6 Countries","volume":"80","author":"Shah","year":"2025","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"2026072715541688200_cit69","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s12879-024-09514-7","article-title":"Association\nbetween HIV and acquisition\nof rifamycin resistance with first-line TB treatment: a systematic\nreview and meta-analysis","volume":"24","author":"Zinyakatira","year":"2024","journal-title":"Bmc Infect Dis"},{"key":"2026072715541688200_cit70","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10369","article-title":"The cyclophilin-Dependent Calcineurin\nInhibitor Voclosporin Inhibits SARS-CoV-2 Replication in Cell Culture","volume":"35","author":"Ogando","year":"2022","journal-title":"Transpl Int."},{"issue":"1","key":"2026072715541688200_cit71","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000525292","article-title":"Pacritinib Inhibition of IRAK1 Blocks\nAberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA","volume":"15","author":"Campbell","year":"2023","journal-title":"J. Innate Immun"},{"issue":"2","key":"2026072715541688200_cit72","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/17460441.2017.1264385","article-title":"Drug discovery beyond\nthe rule of 5 - Opportunities\nand challenges","volume":"12","author":"Doak","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"2026072715541688200_cit73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.addr.2016.03.013","article-title":"Cell permeability beyond\nthe rule of 5","volume":"101","author":"Matsson","year":"2016","journal-title":"Adv. Drug Deliv Rev."},{"issue":"6","key":"2026072715541688200_cit74","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1021\/acs.jmedchem.5b01286","article-title":"How Beyond Rule of\n5 Drugs and Clinical Candidates Bind to Their Targets","volume":"59","author":"Doak","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026072715541688200_cit75","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nchembio.2200","article-title":"Structural\nbasis for precursor protein-directed ribosomal peptide macrocyclization","volume":"12","author":"Li","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"2026072715541688200_cit76","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41589-022-01116-1","article-title":"Discovery and molecular basis of subtype-selective\ncyclophilin inhibitors","volume":"18","author":"Peterson","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"2026072715541688200_cit77","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/s41557-020-0525-1","article-title":"Ribosomal\nsynthesis and de novo discovery of bioactive foldamer peptides containing\ncyclic beta-amino acids","volume":"12","author":"Katoh","year":"2020","journal-title":"Nat. Chem."},{"issue":"17","key":"2026072715541688200_cit78","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1021\/acs.chemrev.8b00807","article-title":"Crystal Structures\nof Protein-Bound Cyclic Peptides","volume":"119","author":"Malde","year":"2019","journal-title":"Chem. Rev."},{"issue":"24","key":"2026072715541688200_cit79","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1021\/acs.accounts.3c00585","article-title":"Molecular Recognition with Macrocyclic\nReceptors for Application in Precision Medicine","volume":"56","author":"Pan","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"2026072715541688200_cit80","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41467-021-21875-0","article-title":"Lasso-grafting of macrocyclic\npeptide pharmacophores\nyields multi-functional proteins","volume":"12","author":"Mihara","year":"2021","journal-title":"Nat. Commun."},{"issue":"6624","key":"2026072715541688200_cit81","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1126\/science.adf4412","article-title":"Getting bifunctional\nmolecules into cells","volume":"378","author":"Lokey","year":"2022","journal-title":"Science"},{"issue":"17","key":"2026072715541688200_cit82","doi-asserted-by":"publisher","first-page":"10241","DOI":"10.1021\/acs.chemrev.9b00008","article-title":"Understanding Cell Penetration of\nCyclic Peptides","volume":"119","author":"Dougherty","year":"2019","journal-title":"Chem. Rev."},{"key":"2026072715541688200_cit83","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pharmthera.2017.02.014","article-title":"Targeting\nkinase signaling pathways\nwith constrained peptide scaffolds","volume":"173","author":"Hanold","year":"2017","journal-title":"Pharmacol\nTher"},{"issue":"21","key":"2026072715541688200_cit84","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1016\/j.cell.2022.09.019","article-title":"State-selective\nmodulation of heterotrimeric Galphas signaling with macrocyclic peptides","volume":"185","author":"Dai","year":"2022","journal-title":"Cell"},{"issue":"4","key":"2026072715541688200_cit85","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/bip.22625","article-title":"Targeting protein-protein interfaces\nusing macrocyclic peptides","volume":"104","author":"Gao","year":"2015","journal-title":"Biopolymers"},{"issue":"26","key":"2026072715541688200_cit86","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202203016","article-title":"Modular Introduction of endo-Binding\nSites in a Macrocyclic Cavity towards Selective Recognition of Neutral\nAzacycles","volume":"61","author":"Xu","year":"2022","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"6546","key":"2026072715541688200_cit87","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.abg3029","article-title":"Sense codon reassignment\nenables viral resistance and encoded polymer synthesis","volume":"372","author":"Robertson","year":"2021","journal-title":"Science"},{"issue":"1","key":"2026072715541688200_cit88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1021\/acschembio.7b00852","article-title":"Design and Application\nof a DNA-Encoded Macrocyclic Peptide Library","volume":"13","author":"Zhu","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"2026072715541688200_cit89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314383121","article-title":"Short macrocyclic\npeptides in sponge genomes","volume":"121","author":"Lin","year":"2024","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"issue":"1","key":"2026072715541688200_cit90","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1038\/s41467-023-41892-5","article-title":"Development of cyclopeptide inhibitors of cGAS targeting\nprotein-DNA\ninteraction and phase separation","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"2026072715541688200_cit91","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tips.2021.11.008","article-title":"Targeting intracellular\nprotein-protein interactions with macrocyclic\npeptides","volume":"43","author":"Buyanova","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"2026072715541688200_cit92","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tips.2021.02.004","article-title":"Discovery of De Novo\nMacrocyclic Peptides by Messenger RNA Display","volume":"42","author":"Peacock","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"46","key":"2026072715541688200_cit93","doi-asserted-by":"publisher","first-page":"19520","DOI":"10.1039\/D4SC04026K","article-title":"Cyclic peptides\ntargeting the SARS-CoV-2\nprogrammed ribosomal frameshifting RNA from a multiplexed phage display\nlibrary","volume":"15","author":"Iannuzzelli","year":"2024","journal-title":"Chemical Science"},{"issue":"10","key":"2026072715541688200_cit94","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00717-20","article-title":"Targeting the Respiratory Syncytial Virus N(0)-P\nComplex with Constrained alpha-Helical Peptides in Cells and Mice","volume":"64","author":"Galloux","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"26","key":"2026072715541688200_cit95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303292120","article-title":"A broad-spectrum\nmacrocyclic peptide inhibitor\nof the SARS-CoV-2 spike protein","volume":"120","author":"Thijssen","year":"2023","journal-title":"Proc. Natl.\nAcad. Sci. U. S. A."},{"issue":"7","key":"2026072715541688200_cit96","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.chembiol.2018.04.011","article-title":"De Novo Macrocyclic Peptide Inhibitors of Hepatitis\nB Virus Cellular Entry","volume":"25","author":"Passioura","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"2026072715541688200_cit97","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1021\/jacs.4c15843","article-title":"Identification of Covalent\nCyclic Peptide Inhibitors Targeting Protein-Protein\nInteractions Using Phage Display","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem.\nSoc."},{"issue":"1","key":"2026072715541688200_cit98","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1038\/s41467-021-22964-w","article-title":"Macrocyclic\npeptides exhibit antiviral effects\nagainst influenza virus HA and prevent pneumonia in animal models","volume":"12","author":"Saito","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"2026072715541688200_cit99","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug Repurposing for\nViral Infectious\nDiseases: How Far Are We?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol"},{"issue":"10","key":"2026072715541688200_cit100","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1093\/cid\/ciaa1341","article-title":"Repurposing\nIvermectin as an Anti-dengue Drug","volume":"72","author":"Ooi","year":"2021","journal-title":"Clin Infect\nDis"},{"issue":"5","key":"2026072715541688200_cit101","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.molcel.2022.01.012","article-title":"Cleavage\nof viral DNA by restriction endonucleases stimulates the type II CRISPR-Cas\nimmune response","volume":"82","author":"Maguin","year":"2022","journal-title":"Mol. Cell"},{"issue":"5","key":"2026072715541688200_cit102","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2015.04.027","article-title":"Co-transcriptional\nDNA and RNA Cleavage\nduring Type III CRISPR-Cas Immunity","volume":"161","author":"Samai","year":"2015","journal-title":"Cell"},{"issue":"3","key":"2026072715541688200_cit103","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.chom.2017.07.016","article-title":"Broad Targeting\nSpecificity during Bacterial Type III\nCRISPR-Cas Immunity Constrains Viral Escape","volume":"22","author":"Pyenson","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"6","key":"2026072715541688200_cit104","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/cells11060999","article-title":"Principles and Applications of CRISPR\nToolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions","volume":"11","author":"Jamehdor","year":"2022","journal-title":"Cells"},{"issue":"3","key":"2026072715541688200_cit105","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cell.2020.12.017","article-title":"A natural\nsingle-guide RNA repurposes\nCas9 to autoregulate CRISPR-Cas expression","volume":"184","author":"Workman","year":"2021","journal-title":"Cell"},{"issue":"1","key":"2026072715541688200_cit106","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.chom.2021.11.014","article-title":"Bacteriostatic antibiotics\npromote CRISPR-Cas adaptive immunity by enabling increased spacer\nacquisition","volume":"30","author":"Dimitriu","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"5","key":"2026072715541688200_cit107","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tibs.2015.03.006","article-title":"Changed\nin translation:\nmRNA recoding by \u22121 programmed ribosomal frameshifting","volume":"40","author":"Caliskan","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"2026072715541688200_cit108","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-021-23068-1","article-title":"Context-specific\naction of macrolide\nantibiotics on the eukaryotic ribosome","volume":"12","author":"Svetlov","year":"2021","journal-title":"Nat.\nCommun."},{"issue":"7","key":"2026072715541688200_cit109","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00430-24","article-title":"Machine\nlearning-based classification reveals distinct clusters of non-coding\ngenomic allelic variations associated with Erm-mediated antibiotic\nresistance","volume":"9","author":"Tan","year":"2024","journal-title":"mSystems"},{"issue":"5","key":"2026072715541688200_cit110","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2023.01.043","article-title":"Discovery of natural-product-derived sequanamycins\nas potent oral anti-tuberculosis agents","volume":"186","author":"Zhang","year":"2023","journal-title":"Cell"},{"issue":"11","key":"2026072715541688200_cit111","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9020","article-title":"Structural basis for motilin and erythromycin\nrecognition by motilin\nreceptor","volume":"9","author":"You","year":"2023","journal-title":"Sci. Adv."},{"issue":"17","key":"2026072715541688200_cit112","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1016\/j.bpj.2023.07.024","article-title":"Binding\nof viral nuclear localization signal peptides to importin-alpha nuclear\ntransport protein","volume":"122","author":"Delfing","year":"2023","journal-title":"Biophys. J."},{"key":"2026072715541688200_cit113","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.56","article-title":"Inhibition of glycogen synthase kinase 3\u03b2 promotes autophagy\nto protect mice from acute liver failure mediated by peroxisome proliferator-activated\nreceptor \u03b1","volume":"7","author":"Ren","year":"2016","journal-title":"Cell Death Dis"},{"issue":"10","key":"2026072715541688200_cit114","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156063","article-title":"Rapamycin\nlimits CD4 T cell proliferation in simian immunodeficiency virus-infected\nrhesus macaques on antiretroviral therapy","volume":"132","author":"Varco-Merth","year":"2022","journal-title":"J.\nClin. Invest."},{"issue":"1","key":"2026072715541688200_cit115","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12915-024-01819-y","article-title":"The temporal\nassociation of CapZ with early endosomes regulates endosomal trafficking\nand viral entry into host cells","volume":"22","author":"Zhu","year":"2024","journal-title":"BMC Biol."},{"issue":"10","key":"2026072715541688200_cit116","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41429-019-0204-x","article-title":"Azithromycin,\na 15-membered\nmacrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection\nby interfering with virus internalization process","volume":"72","author":"Tran","year":"2019","journal-title":"J. Antibiot (Tokyo)"},{"issue":"10","key":"2026072715541688200_cit117","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1021\/acs.jmedchem.4c00319","article-title":"Modular\nBiomimetic Strategy Enables Discovery and SAR Exploration\nof Oxime Macrocycles as Influenza A Virus (H1N1) Inhibitors","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026072715541688200_cit118","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1021\/acs.jcim.0c01394","article-title":"Macrolides May Prevent Severe Acute Respiratory Syndrome\nCoronavirus 2 Entry into Cells: A Quantitative Structure Activity\nRelationship Study and Experimental Validation","volume":"61","author":"Galvez","year":"2021","journal-title":"J. Chem. Inf Model"},{"issue":"499","key":"2026072715541688200_cit119","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap8758","article-title":"Heterogeneous antiretroviral\ndrug distribution and HIV\/SHIV detection in the gut of three species","volume":"11","author":"Thompson","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"2026072715541688200_cit120","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.jhep.2015.08.010","article-title":"Management of direct-acting\nantiviral agent failures","volume":"63","author":"Buti","year":"2015","journal-title":"J. Hepatol"},{"key":"2026072715541688200_cit121","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8976-8_1","article-title":"Overview\nof Direct-Acting Antiviral\nDrugs and Drug Resistance of Hepatitis C Virus","volume":"1911","author":"Li","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"2026072715541688200_cit122","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1021\/acs.chemrev.0c00648","article-title":"Drug Design Strategies\nto Avoid Resistance in Direct-Acting Antivirals and Beyond","volume":"121","author":"Matthew","year":"2021","journal-title":"Chem. Rev."},{"issue":"7","key":"2026072715541688200_cit123","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1039\/D0CS01084G","article-title":"Medicinal\nchemistry strategies for discovering antivirals effective against\ndrug-resistant viruses","volume":"50","author":"Ma","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"2026072715541688200_cit124","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cmi.2020.10.002","article-title":"Effect of hydroxychloroquine with\nor without azithromycin on the mortality of COVID-19 patients: authors\u2019\nresponse","volume":"27","author":"Fiolet","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"2026072715541688200_cit125","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1124\/pharmrev.121.000300","article-title":"Nonantimicrobial\nActions of Macrolides: Overview and Perspectives for Future Development","volume":"73","author":"Kricker","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"10256","key":"2026072715541688200_cit126","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(20)31863-8","article-title":"Azithromycin for severe COVID-19","volume":"396","author":"Oldenburg","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"2026072715541688200_cit127","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00379-9","article-title":"Azithromycin for mild-to-moderate\nCOVID-19","volume":"9","author":"Patel","year":"2021","journal-title":"Lancet Respir Med."},{"issue":"9","key":"2026072715541688200_cit128","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jamacardio.2020.1782","article-title":"Hydroxychloroquine,\nCoronavirus Disease 2019, and QT Prolongation","volume":"5","author":"Bonow","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026072715541688200_cit129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.134102","article-title":"NaClO Co-selects antibiotic and disinfectant resistance in Klebsiella\npneumonia: Implications for the potential risk of extensive disinfectant\nuse during COVID-19 pandemic","volume":"470","author":"Chen","year":"2024","journal-title":"J. Hazard Mater."},{"issue":"4","key":"2026072715541688200_cit130","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1473-3099(22)00735-6","article-title":"Efficacy and safety\nof azithromycin versus placebo to treat lower respiratory tract infections\nassociated with low procalcitonin: a randomised, placebo-controlled,\ndouble-blind, non-inferiority trial","volume":"23","author":"Tsalik","year":"2023","journal-title":"Lancet\nInfect Dis"},{"issue":"1","key":"2026072715541688200_cit131","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","article-title":"Direct anti-HCV agents","volume":"6","author":"Zhang","year":"2016","journal-title":"Acta\nPharm. Sin B"},{"issue":"2","key":"2026072715541688200_cit132","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jhep.2014.08.052","article-title":"Safety profile of boceprevir and telaprevir in chronic hepatitis\nC: real world experience from HCV-TARGET","volume":"62","author":"Gordon","year":"2015","journal-title":"J.\nHepatol"},{"issue":"2","key":"2026072715541688200_cit133","doi-asserted-by":"publisher","first-page":"160","DOI":"10.14218\/JCTH.2020.00105","article-title":"Histone deacetylase\nInhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication\nby Inducing Cell Cycle Arrest","volume":"9","author":"Yang","year":"2021","journal-title":"J. Clin. Transl.\nHepatol."},{"issue":"3","key":"2026072715541688200_cit134","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1016\/S2666-5247(21)00239-1","article-title":"Effect of 3BNC117 and\nromidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral\ntherapy (ROADMAP): a randomised, open-label, phase 2A trial","volume":"3","author":"Gruell","year":"2022","journal-title":"Lancet Microbe"},{"issue":"7","key":"2026072715541688200_cit135","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/apt.15656","article-title":"Editorial: glecaprevir\/pibrentasvir\nfor the treatment of hepatitis C virus-do baseline resistance-associated\nsubstitutions matter?","volume":"51","author":"Kwong","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"2026072715541688200_cit136","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1093\/jac\/dkaa304","article-title":"Prevalence of resistance-associated\nsubstitutions and retreatment of patients failing a glecaprevir\/pibrentasvir\nregimen","volume":"75","author":"de Salazar","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"2026072715541688200_cit137","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S2468-1253(21)00399-X","article-title":"Safety and efficacy\nof sofosbuvir-velpatasvir-voxilaprevir for re-treatment\nof chronic hepatitis C virus infection in patients with previous direct-acting\nantiviral treatment failure in Rwanda (SHARED-3): a single-arm trial","volume":"7","author":"Gupta","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"2026072715541688200_cit138","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jhep.2018.07.023","article-title":"No impact\nof resistance-associated substitutions on the efficacy of sofosbuvir,\nvelpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced\npatients","volume":"69","author":"Sarrazin","year":"2018","journal-title":"J. Hepatol"},{"issue":"22","key":"2026072715541688200_cit139","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir,\nVelpatasvir, and Voxilaprevir for Previously Treated HCV Infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N Engl J. Med."},{"key":"2026072715541688200_cit140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.115035","article-title":"Chemical\nscaffold recycling: Structure-guided conversion of an HIV integrase\ninhibitor into a potent influenza virus RNA-dependent RNA polymerase\ninhibitor designed to minimize resistance potential","volume":"247","author":"Slavish","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"2026072715541688200_cit141","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12977-021-00575-z","article-title":"Altered\nEnv conformational dynamics as a mechanism of resistance to peptide-triazole\nHIV-1 inactivators","volume":"18","author":"Zhang","year":"2021","journal-title":"Retrovirology"},{"issue":"3","key":"2026072715541688200_cit142","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/hep.30647","article-title":"Evolutionary\nPathways\nto Persistence of Highly Fit and Resistant Hepatitis C Virus Protease\nInhibitor Escape Variants","volume":"70","author":"Jensen","year":"2019","journal-title":"Hepatology"},{"issue":"12","key":"2026072715541688200_cit143","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1080\/07391102.2020.1869587","article-title":"Exploring of paritaprevir and glecaprevir\nresistance\ndue to A156T mutation of HCV NS3\/4A protease: molecular dynamics simulation\nstudy","volume":"40","author":"Boonma","year":"2022","journal-title":"J. Biomol Struct Dyn"},{"issue":"4","key":"2026072715541688200_cit144","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1021\/acschembio.5b00647","article-title":"Structural\nand Thermodynamic\nEffects of Macrocyclization in HCV NS3\/4A Inhibitor MK-5172","volume":"11","author":"Soumana","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"2026072715541688200_cit145","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41467-025-56317-8","article-title":"Macrocycle-based\nPROTACs\nselectively degrade cyclophilin A and inhibit HIV-1 and HCV","volume":"16","author":"Newton","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"2026072715541688200_cit146","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jhep.2014.11.009","article-title":"Hepatitis\nC virus variants resistant to macrocyclic NS3\u20134A inhibitors\nsubvert IFN-beta induction by efficient MAVS cleavage","volume":"62","author":"Welsch","year":"2015","journal-title":"J. Hepatol"},{"issue":"4","key":"2026072715541688200_cit147","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1021\/acs.jmedchem.3c01715","article-title":"Discovery of a Macrocyclic Influenza Cap-Dependent\nEndonuclease Inhibitor","volume":"67","author":"Feng","year":"2024","journal-title":"J. Med. Chem."},{"issue":"16","key":"2026072715541688200_cit148","doi-asserted-by":"publisher","first-page":"11972","DOI":"10.1021\/acs.jmedchem.1c00554","article-title":"Discovery of Quinoxaline-Based\nP1-P3Macrocyclic NS3\/4A Protease Inhibitors with Potent Activity against\nDrug-Resistant Hepatitis C Virus Variants","volume":"64","author":"Nageswara Rao","year":"2021","journal-title":"J.\nMed. Chem."},{"issue":"8","key":"2026072715541688200_cit149","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1021\/acs.accounts.7b00184","article-title":"Phage Selection of\nCyclic Peptides for Application in Research and Drug Development","volume":"50","author":"Deyle","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"13","key":"2026072715541688200_cit150","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1021\/acs.orglett.4c00602","article-title":"Asparaginyl\nEndopeptidase-Mediated\nPeptide Cyclization for Phage Display","volume":"26","author":"Wan","year":"2024","journal-title":"Org.\nLett."},{"key":"2026072715541688200_cit151","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejmech.2014.03.011","article-title":"Disulfide-rich\nmacrocyclic peptides as templates in drug design","volume":"77","author":"Northfield","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"2026072715541688200_cit152","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1021\/jacs.1c12822","article-title":"A Strategy\nto Select Macrocyclic Peptides Featuring Asymmetric Molecular Scaffolds\nas Cyclization Units by Phage Display","volume":"144","author":"Oppewal","year":"2022","journal-title":"J. Am.\nChem. Soc."},{"issue":"18","key":"2026072715541688200_cit153","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1021\/acs.accounts.1c00391","article-title":"The RaPID Platform for the Discovery\nof Pseudo-Natural Macrocyclic Peptides","volume":"54","author":"Goto","year":"2021","journal-title":"Acc.\nChem. Res."},{"issue":"1","key":"2026072715541688200_cit154","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41467-021-20992-0","article-title":"Posttranslational chemical installation of azoles into translated\npeptides","volume":"12","author":"Tsutsumi","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"2026072715541688200_cit155","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41557-023-01205-1","article-title":"In vitro selection of\nmacrocyclic peptide inhibitors containing cyclic gamma(2,4)-amino\nacids targeting the SARS-CoV-2 main protease","volume":"15","author":"Miura","year":"2023","journal-title":"Nat. Chem."},{"issue":"25","key":"2026072715541688200_cit156","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1021\/jacs.2c02824","article-title":"Accessing Diverse Pyridine-Based\nMacrocyclic Peptides by a Two-Site Recognition Pathway","volume":"144","author":"Nguyen","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"2026072715541688200_cit157","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1021\/acs.accounts.7b00130","article-title":"Protein\nDomain Mimics\nas Modulators of Protein-Protein Interactions","volume":"50","author":"Sawyer","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"5","key":"2026072715541688200_cit158","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1021\/acsbiomedchemau.3c00027","article-title":"Macrocyclic\nPeptides\nClosed by a Thioether-Bipyridyl Unit That Grants Cell Membrane Permeability","volume":"3","author":"Chen","year":"2023","journal-title":"ACS Bio Med. Chem. Au"},{"issue":"32","key":"2026072715541688200_cit159","doi-asserted-by":"publisher","first-page":"17613","DOI":"10.1021\/jacs.3c02943","article-title":"Modification\nof Low-Energy Surfaces Using Bicyclic Peptides Discovered by Phage\nDisplay","volume":"145","author":"Wang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"17","key":"2026072715541688200_cit160","doi-asserted-by":"publisher","first-page":"9836","DOI":"10.1021\/acs.chemrev.8b00744","article-title":"Multicomponent Reaction\nToolbox for\nPeptide Macrocyclization and Stapling","volume":"119","author":"Reguera","year":"2019","journal-title":"Chem.\nRev."},{"issue":"43","key":"2026072715541688200_cit161","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202208400","article-title":"Biocompatible and Selective Generation of Bicyclic\nPeptides","volume":"61","author":"Ullrich","year":"2022","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"5","key":"2026072715541688200_cit162","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/med.22039","article-title":"A promising future\nof metal-N-heterocyclic carbene complexes in medicinal chemistry:\nThe emerging bioorganometallic antitumor agents","volume":"44","author":"Zhao","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"10","key":"2026072715541688200_cit163","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202318615","article-title":"Cell-Penetrating Peptide-Bismuth Bicycles","volume":"63","author":"Voss","year":"2024","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"4","key":"2026072715541688200_cit164","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202113857","article-title":"Peptide-Bismuth\nBicycles:\nIn Situ Access to Stable Constrained Peptides with Superior Bioactivity","volume":"61","author":"Voss","year":"2022","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"1","key":"2026072715541688200_cit165","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1038\/s41467-023-39158-1","article-title":"Multivalent Bicyclic\npeptides are an effective antiviral modality that can potently inhibit\nSARS-CoV-2","volume":"14","author":"Gaynor","year":"2023","journal-title":"Nat. Commun."},{"key":"2026072715541688200_cit166","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejmech.2016.09.063","article-title":"Identification\nof\nfused Bicyclic derivatives of pyrrolidine and imidazolidinone as dengue\nvirus-2 NS2B-NS3 protease inhibitors","volume":"125","author":"Weng","year":"2017","journal-title":"Eur. J.\nMed. Chem."},{"key":"2026072715541688200_cit167","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1021\/acs.jmedchem.2c00406","article-title":"Discovery and Structure-Based Design of Macrocyclic Peptides Targeting\nSTUB1","volume":"65","author":"Ng","year":"2022","journal-title":"J. Med. Chem."},{"issue":"15","key":"2026072715541688200_cit168","doi-asserted-by":"publisher","first-page":"12534","DOI":"10.1021\/acs.jmedchem.4c00411","article-title":"Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads\nto Potent EPHA2\/GAK Kinase Inhibitors","volume":"67","author":"Gerninghaus","year":"2024","journal-title":"J. Med.\nChem."},{"issue":"11","key":"2026072715541688200_cit169","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1021\/acsmedchemlett.4c00427","article-title":"Toward Dual Targeting\nof Catalytic and Gatekeeper Pockets in Cyclophilins Using a Macrocyclic\nScaffold","volume":"15","author":"Dreizler","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"2026072715541688200_cit170","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1021\/acs.jmedchem.5b01464","article-title":"Oxadiazole-Based Cell Permeable Macrocyclic\nTransition State Inhibitors\nof Norovirus 3CL Protease","volume":"59","author":"Damalanka","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026072715541688200_cit171","doi-asserted-by":"publisher","DOI":"10.1016\/j.Bioorg.2021.105363","article-title":"Discovery of novel oxazole-based\nmacrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease","volume":"116","author":"Al-Wahaibi","year":"2021","journal-title":"Bioorg Chem."},{"issue":"37","key":"2026072715541688200_cit172","doi-asserted-by":"publisher","first-page":"7770","DOI":"10.1039\/C7OB01448A","article-title":"Chemical optimization\nof macrocyclic HIV-1 inactivators for improving potency and increasing\nthe structural diversity at the triazole ring","volume":"15","author":"Rashad","year":"2017","journal-title":"Org. Biomol Chem."},{"issue":"11","key":"2026072715541688200_cit173","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.1021\/acs.jmedchem.4c00053","article-title":"Macrocyclic Azapeptide\nNitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease\nInhibitors as Antiviral Drugs","volume":"67","author":"Breidenbach","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026072715541688200_cit174","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.lfs.2018.12.004","article-title":"A comparative study of the efficiency\nof HCV NS3\/4A protease drugs against different HCV genotypes using\nin silico approaches","volume":"217","author":"Ezat","year":"2019","journal-title":"Life Sci."},{"key":"2026072715541688200_cit175","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejmech.2016.04.013","article-title":"Structure-based\ndesign and synthesis of triazole-based macrocyclic inhibitors of norovirus\nprotease: Structural, biochemical, spectroscopic, and antiviral studies","volume":"119","author":"Weerawarna","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"2026072715541688200_cit176","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1039\/D2CC06371A","article-title":"Synthesis of maleimide-braced peptide macrocycles\nand\ntheir potential anti-SARS-CoV-2 mechanisms","volume":"59","author":"Li","year":"2023","journal-title":"Chem. Commun. (Camb)"},{"issue":"6","key":"2026072715541688200_cit177","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1021\/acs.bioconjchem.3c00159","article-title":"Synthesis of a DNA-Encoded\nMacrocyclic Library Utilizing Intramolecular Benzimidazole Formation","volume":"34","author":"Chai","year":"2023","journal-title":"Bioconjug Chem."},{"issue":"6","key":"2026072715541688200_cit178","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1021\/acs.orglett.6b00331","article-title":"A Synthesis of a Spirocyclic\nMacrocyclic\nProtease Inhibitor for the Treatment of Hepatitis C","volume":"18","author":"Chung","year":"2016","journal-title":"Org. Lett."},{"issue":"5","key":"2026072715541688200_cit179","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and\ntherapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov"},{"issue":"9","key":"2026072715541688200_cit180","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.tim.2018.02.007","article-title":"Within-Host\nEvolution of Human Influenza Virus","volume":"26","author":"Xue","year":"2018","journal-title":"Trends Microbiol"},{"issue":"3","key":"2026072715541688200_cit181","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00168-19","article-title":"Host-Directed Antiviral\nTherapy","volume":"33","author":"Kumar","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"2026072715541688200_cit182","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jconrel.2022.01.046","article-title":"Strategies\nfor fighting pandemic virus infections: Integration of virology and\ndrug delivery","volume":"343","author":"Nakamura","year":"2022","journal-title":"J. Controlled Release"},{"issue":"5","key":"2026072715541688200_cit183","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab029","article-title":"Current status\nand future perspectives of computational studies on human-virus protein-protein\ninteractions","volume":"22","author":"Lian","year":"2021","journal-title":"Briefings Bioinf."},{"key":"2026072715541688200_cit184","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and\nstrategies to combat viral infections: A review on FDA approved antiviral\ndrugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"2026072715541688200_cit185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-16-8702-0_1","article-title":"Virus Entry\nInhibitors: Past, Present,\nand Future","volume":"1366","author":"Su","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"13","key":"2026072715541688200_cit186","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.jmb.2018.03.034","article-title":"Virus Entry: Looking Back and Moving\nForward","volume":"430","author":"Helenius","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"8","key":"2026072715541688200_cit187","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1128\/JVI.02568-15","article-title":"Virus and Host Mechanics Support\nMembrane Penetration\nand Cell Entry","volume":"90","author":"Greber","year":"2016","journal-title":"J. Virol"},{"issue":"1","key":"2026072715541688200_cit188","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-virology-122019-070025","article-title":"Initial Step of Virus Entry: Virion\nBinding to Cell-Surface\nGlycans","volume":"7","author":"Koehler","year":"2020","journal-title":"Annu. Rev. Virol"},{"issue":"6703","key":"2026072715541688200_cit189","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1126\/science.adq3348","article-title":"Antibody inhibition of measles virus\nentry","volume":"384","author":"Aguilar","year":"2024","journal-title":"Science"},{"issue":"10","key":"2026072715541688200_cit190","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.tibs.2021.06.001","article-title":"Cell entry by SARS-CoV-2","volume":"46","author":"Peng","year":"2021","journal-title":"Trends\nBiochem. Sci."},{"issue":"1","key":"2026072715541688200_cit191","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1021\/acschembio.3c00568","article-title":"Discovery\nof High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2\nEntry Inhibitory Activity","volume":"19","author":"Bedding","year":"2024","journal-title":"ACS Chem. Biol."},{"issue":"43","key":"2026072715541688200_cit192","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq6207","article-title":"De novo selected hACE2 mimics that\nintegrate hotspot peptides with aptameric scaffolds for binding tolerance\nof SARS-CoV-2 variants","volume":"8","author":"Lee","year":"2022","journal-title":"Sci. Adv."},{"issue":"3","key":"2026072715541688200_cit193","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2021.103631","article-title":"Development of superior antibodies\nagainst the S-protein of SARS-Cov-2 using macrocyclic epitopes","volume":"15","author":"Traboulsi","year":"2022","journal-title":"Arab J. Chem."},{"issue":"2","key":"2026072715541688200_cit194","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41429-021-00491-6","article-title":"The mechanisms\nof action of ivermectin\nagainst SARS-CoV-2-an extensive review","volume":"75","author":"Zaidi","year":"2022","journal-title":"J. Antibiot\n(Tokyo)"},{"issue":"5","key":"2026072715541688200_cit195","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.21873\/invivo.12134","article-title":"Ivermectin Docks to the SARS-CoV-2\nSpike Receptor-binding Domain Attached to ACE2","volume":"34","author":"Lehrer","year":"2020","journal-title":"In Vivo"},{"key":"2026072715541688200_cit196","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-0716-2635-1_8","article-title":"Receptor-Binding Specificity\nof Influenza Viruses","volume":"2556","author":"Imai","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"2026072715541688200_cit197","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1021\/acschembio.2c00040","article-title":"Inhibition of H1 and\nH5 Influenza A Virus Entry by\nDiverse Macrocyclic Peptides Targeting the Hemagglutinin Stem Region","volume":"17","author":"Pascha","year":"2022","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"2026072715541688200_cit198","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr1018","article-title":"Affinity selection-mass spectrometry\nwith linearizable\nmacrocyclic peptide libraries","volume":"11","author":"Lee","year":"2025","journal-title":"Sci. Adv."},{"issue":"38","key":"2026072715541688200_cit199","doi-asserted-by":"publisher","first-page":"10561","DOI":"10.1039\/D3SC03117A","article-title":"Selective thiazoline\npeptide cyclisation compatible with mRNA display and efficient synthesis","volume":"14","author":"Liu","year":"2023","journal-title":"Chem. Sci."},{"issue":"10","key":"2026072715541688200_cit200","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.tim.2019.06.002","article-title":"Molecular Mechanism of HIV-1 Entry","volume":"27","author":"Chen","year":"2019","journal-title":"Trends\nMicrobiol"},{"issue":"2","key":"2026072715541688200_cit201","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijpharm.2015.09.027","article-title":"Superiority\nof the S,S conformation in diverse pharmacological processes: Intestinal\ntransport and entry inhibition activity of novel anti-HIV drug lead","volume":"495","author":"Fanous","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"18","key":"2026072715541688200_cit202","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1021\/acs.jmedchem.5b00935","article-title":"Macrocyclic Envelope\nGlycoprotein Antagonists that\nIrreversibly Inactivate HIV-1 before Host Cell Encounter","volume":"58","author":"Rashad","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026072715541688200_cit203","doi-asserted-by":"publisher","first-page":"29764","DOI":"10.1038\/s41598-024-77106-1","article-title":"Cutting-edge\nBioinformatics strategies for synthesizing Cyclotriazadisulfonamide\n(CADA) analogs in next-Generation HIV therapies","volume":"14","author":"Larga","year":"2024","journal-title":"Sci. Rep"},{"issue":"24","key":"2026072715541688200_cit204","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115816","article-title":"Syntheses\nand anti-HIV and human\ncluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused\ncyclotriazadisulfonamide (CADA) compounds","volume":"28","author":"Lumangtad","year":"2020","journal-title":"Bioorg.\nMed. Chem."},{"issue":"6","key":"2026072715541688200_cit205","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1021\/acs.jmedchem.5b01832","article-title":"Tuning Side Arm\nElectronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic\nReticulum (ER) Translocation Inhibitors to Improve their Human Cluster\nof Differentiation 4 (CD4) Receptor Down-Modulating potencies","volume":"59","author":"Chawla","year":"2016","journal-title":"J. Med. Chem."},{"issue":"24","key":"2026072715541688200_cit206","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115818","article-title":"Discovery of a potent\ndual inhibitor of wild-type and mutant respiratory syncytial virus\nfusion proteins through the modulation of atropisomer interconversion\nproperties","volume":"28","author":"Yamaguchi-Sasaki","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"2026072715541688200_cit207","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41589-018-0122-4","article-title":"Substrate-assisted\nenzymatic formation\nof lysinoalanine in duramycin","volume":"14","author":"An","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"2026072715541688200_cit208","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105767","article-title":"Antiviral activity of\nporphyrins and porphyrin-like compounds against tick-borne encephalitis\nvirus: Blockage of the viral entry\/fusion machinery by photosensitization-mediated\ndestruction of the viral envelope","volume":"221","author":"Holoubek","year":"2024","journal-title":"Antiviral\nRes."},{"issue":"8","key":"2026072715541688200_cit209","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1021\/acsinfecdis.3c00063","article-title":"Peptidomimetic\nOligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral\nActivity","volume":"9","author":"Tate","year":"2023","journal-title":"ACS Infect Dis"},{"issue":"29","key":"2026072715541688200_cit210","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.2174\/0929867323666160510122525","article-title":"Macrocyclic Hepatitis\nC Virus NS3\/4A Protease Inhibitors: An Overview of Medicinal Chemistry","volume":"23","author":"Pillaiyar","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"2026072715541688200_cit211","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved Antiviral\nDrugs over the\nPast 50 Years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev."},{"issue":"15","key":"2026072715541688200_cit212","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.molcel.2023.06.023","article-title":"Structures\nof dengue virus RNA replicase complexes","volume":"83","author":"Osawa","year":"2023","journal-title":"Mol.\nCell"},{"issue":"1","key":"2026072715541688200_cit213","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biotechadv.2017.09.004","article-title":"Zika virus\nstructural biology and progress in vaccine development","volume":"36","author":"Lin","year":"2018","journal-title":"Biotechnol Adv."},{"key":"2026072715541688200_cit214","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.coph.2016.07.015","article-title":"Hepatitis C virus\nNS3\/4a protease\ninhibitors","volume":"30","author":"McCauley","year":"2016","journal-title":"Curr. Opin Pharmacol"},{"issue":"12","key":"2026072715541688200_cit215","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S2468-1253(18)30271-1","article-title":"HCV core antigen as\nan alternative to HCV RNA testing in the era of direct-acting antivirals:\nretrospective screening and diagnostic cohort studies","volume":"3","author":"van Tilborg","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"2026072715541688200_cit216","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jhep.2016.07.023","article-title":"Diagnostics\nin hepatitis C: The end\nof response-guided therapy?","volume":"65","author":"Maasoumy","year":"2016","journal-title":"J. Hepatol."},{"issue":"6","key":"2026072715541688200_cit217","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/apt.13514","article-title":"Review article:\nsafety and tolerability\nof direct-acting anti-viral agents in the new era of hepatitis C therapy","volume":"43","author":"Banerjee","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2026072715541688200_cit218","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jhep.2019.07.020","article-title":"Real-life\neffectiveness\nand safety of sofosbuvir\/velpatasvir\/voxilaprevir in hepatitis C patients\nwith previous DAA failure","volume":"71","author":"Degasperi","year":"2019","journal-title":"J. Hepatol"},{"issue":"3","key":"2026072715541688200_cit219","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01888-19","article-title":"Cell Culture Studies\nof the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir\nand Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a,\n2b, and 2c","volume":"64","author":"Ramirez","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"2026072715541688200_cit220","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.jhep.2021.03.004","article-title":"Treatment failure with DAA therapy: Importance of resistance","volume":"74","author":"Sarrazin","year":"2021","journal-title":"J. Hepatol"},{"issue":"9","key":"2026072715541688200_cit221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167503","article-title":"Deciphering the Molecular\nMechanism of HCV Protease Inhibitor Fluorination as a General Approach\nto Avoid Drug Resistance","volume":"434","author":"Zephyr","year":"2022","journal-title":"J. Mol. Biol."},{"issue":"2","key":"2026072715541688200_cit222","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1128\/AAC.01913-15","article-title":"Drug-Drug Interactions\nbetween Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir with or without\nDasabuvir","volume":"60","author":"King","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"2026072715541688200_cit223","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1053\/j.gastro.2016.05.021","article-title":"Efficacy of the Combination of Sofosbuvir, Velpatasvir,\nand the NS3\/4A Protease Inhibitor GS-9857 in Treatment-Naive or Previously\nTreated Patients With Hepatitis C Virus Genotype 1 or 3 Infections","volume":"151","author":"Gane","year":"2016","journal-title":"Gastroenterology"},{"key":"2026072715541688200_cit224","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejmech.2019.01.025","article-title":"Hepatitis C - New drugs and treatment\nprospects","volume":"165","author":"Zajac","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"2026072715541688200_cit225","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/apt.14977","article-title":"Review article:\nnovel antivirals\nfor hepatitis C-sofosbuvir\/velpatasvir\/voxilaprevir, glecaprevir\/pibrentasvir","volume":"48","author":"Pearlman","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2026072715541688200_cit226","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jhep.2020.11.017","article-title":"Failure\non voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy","volume":"74","author":"Dietz","year":"2021","journal-title":"J. Hepatol"},{"issue":"5","key":"2026072715541688200_cit227","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40265-018-0895-5","article-title":"Sofosbuvir\/Velpatasvir\/Voxilaprevir:\nA Review in Chronic Hepatitis C","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"2026072715541688200_cit228","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116733","article-title":"Macrocyclic-based strategy\nin drug design: From lab to the clinic","volume":"277","author":"Jin","year":"2024","journal-title":"Eur.\nJ. Med. Chem."},{"key":"2026072715541688200_cit229","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.116051","article-title":"Exploring the synthetic approaches and clinical prowess of established\nmacrocyclic pharmaceuticals","volume":"264","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"2026072715541688200_cit230","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/acschembio.9b00675","article-title":"Molecular and Structural\nMechanism of Pan-Genotypic HCV NS3\/4A Protease Inhibition by Glecaprevir","volume":"15","author":"Timm","year":"2020","journal-title":"ACS Chem. Biol."},{"issue":"4","key":"2026072715541688200_cit231","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1021\/acs.oprd.1c00315","article-title":"Development\nof the Enabling\nRoute for a Novel HCV NS3\/4A Inhibitor","volume":"26","author":"Zhang","year":"2022","journal-title":"Furaprevir.\nOrg. Process Res. Dev"},{"issue":"12","key":"2026072715541688200_cit232","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1021\/acs.orglett.5b01216","article-title":"Toward the\nSynthesis of Fluorinated Analogues of HCV NS3\/4A Serine Protease Inhibitors\nUsing Methyl alpha-Amino-beta-fluoro-beta-vinylcyclopropanecarboxylate\nas Key Intermediate","volume":"17","author":"Milanole","year":"2015","journal-title":"Org. Lett."},{"issue":"22","key":"2026072715541688200_cit233","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1021\/acs.orglett.8b03173","article-title":"Synthesis\nof Grazoprevir, a Potent NS3\/4a Protease Inhibitor for the Treatment\nof Hepatitis C Virus","volume":"20","author":"Xu","year":"2018","journal-title":"Org. Lett."},{"issue":"2","key":"2026072715541688200_cit234","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acs.oprd.9b00469","article-title":"Development of the Enabling\nRoute for Glecaprevir via Ring-Closing Metathesis","volume":"24","author":"Cink","year":"2020","journal-title":"Org. Process Res. Dev"},{"issue":"6","key":"2026072715541688200_cit235","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1021\/acs.orglett.5b00418","article-title":"Synthesis\nof bis-macrocyclic HCV protease inhibitor\nMK-6325 via intramolecular sp(2)-sp(3) Suzuki-Miyaura coupling and\nring closing metathesis","volume":"17","author":"Li","year":"2015","journal-title":"Org. Lett."},{"issue":"7","key":"2026072715541688200_cit236","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1021\/acsmedchemlett.8b00150","article-title":"Quinoxaline-Based Linear HCV NS3\/4A\nProtease Inhibitors Exhibit Potent Activity against Drug Resistant\nVariants","volume":"9","author":"Rusere","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"2026072715541688200_cit237","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bmcl.2017.11.005","article-title":"The discovery\nand optimization of naphthalene-linked P2-P4Macrocycles as inhibitors\nof HCV NS3 protease","volume":"28","author":"Bowsher","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"2026072715541688200_cit238","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1021\/acs.jmedchem.6b00821","article-title":"Discovery of a Potent\nAcyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus\nNS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily\nDosing","volume":"59","author":"Sun","year":"2016","journal-title":"J. Med. Chem."},{"issue":"19","key":"2026072715541688200_cit239","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1016\/j.bmcl.2010.08.022","article-title":"Novel macrocyclic HCV NS3 protease inhibitors derived from alpha-amino\ncyclic boronates","volume":"20","author":"Li","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"2026072715541688200_cit240","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1021\/acsmedchemlett.6b00321","article-title":"Design\nand Synthesis of P2-P4Macrocycles Containing a Unique Spirocyclic\nProline: A New Class of HCV NS3\/4A Inhibitors","volume":"7","author":"Velazquez","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"2026072715541688200_cit241","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/s41401-018-0046-2","article-title":"GP205, a new hepatitis\nC virus NS3\/4A protease inhibitor,\ndisplays higher metabolic stability in vitro and drug exposure in\nvivo","volume":"39","author":"Zhai","year":"2018","journal-title":"Acta Pharmacol Sin"},{"issue":"13","key":"2026072715541688200_cit242","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1021\/acs.jmedchem.7b00426","article-title":"Hepatitis\nC Virus NS3\/4A Protease\nInhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant\nViral Variants","volume":"60","author":"Matthew","year":"2017","journal-title":"J. Med. Chem."},{"issue":"23","key":"2026072715541688200_cit243","doi-asserted-by":"publisher","first-page":"14740","DOI":"10.1021\/acs.jmedchem.0c01296","article-title":"Discovery of BMS-986144,\na Third-Generation, Pan-Genotype NS3\/4A\nProtease Inhibitor for the Treatment of Hepatitis C Virus Infection","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026072715541688200_cit244","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acs.jcim.1c01326","article-title":"Characterization of an Allosteric Pocket in Zika Virus\nNS2B-NS3 Protease","volume":"62","author":"Santos","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"2026072715541688200_cit245","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202200518","article-title":"Thermodynamic characterization\nof\na macrocyclic Zika virus NS2B\/NS3 protease inhibitor and its acyclic\nanalogs","volume":"356","author":"Hammerschmidt","year":"2023","journal-title":"Arch Pharm. (Weinheim)"},{"issue":"9","key":"2026072715541688200_cit246","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400250","article-title":"Synthesis\nand structural characterization of new macrocyclic inhibitors of the\nZika virus NS2B-NS3 protease","volume":"357","author":"Huber","year":"2024","journal-title":"Arch Pharm. (Weinheim)"},{"issue":"15","key":"2026072715541688200_cit247","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/cmdc.202000237","article-title":"Structure-Based Macrocyclization\nof Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile\nand Dengue viruses","volume":"15","author":"Braun","year":"2020","journal-title":"ChemMedChem."},{"issue":"9","key":"2026072715541688200_cit248","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1021\/acs.jmedchem.1c01860","article-title":"Structure-Based Optimization and\nCharacterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors","volume":"65","author":"Huber","year":"2022","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026072715541688200_cit249","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1021\/acsmedchemlett.0c00657","article-title":"2-Cyanoisonicotinamide\nConjugation: A Facile Approach to Generate Potent Peptide Inhibitors\nof the Zika Virus Protease","volume":"12","author":"Patil","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"2026072715541688200_cit250","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acsmedchemlett.8b00535","article-title":"De Novo Discovery\nof Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of\nthe Zika Virus NS2B-NS3 Protease","volume":"10","author":"Nitsche","year":"2019","journal-title":"ACS Med. Chem.\nLett."},{"key":"2026072715541688200_cit251","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211002621","article-title":"A review: Mechanism\nof action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int. J. Immunopathol.\nPharmacol."},{"issue":"5","key":"2026072715541688200_cit252","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1021\/jm401396p","article-title":"Discovery\nand early\ndevelopment of TMC647055, a non-nucleoside inhibitor of the hepatitis\nC virus NS5B polymerase","volume":"57","author":"Cummings","year":"2014","journal-title":"J. Med. Chem."},{"issue":"33","key":"2026072715541688200_cit253","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.1021\/jacs.1c06226","article-title":"A Self-Regulating DNA\nRotaxane Linear Actuator Driven\nby Chemical Energy","volume":"143","author":"Yu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"2026072715541688200_cit254","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.883060","article-title":"RNA-Binding Macrocyclic Peptides","volume":"9","author":"Pal","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"83","key":"2026072715541688200_cit255","doi-asserted-by":"publisher","first-page":"11668","DOI":"10.1039\/C8CC06716C","article-title":"Design, synthesis,\nand applications of DNA-macrocyclic host conjugates","volume":"54","author":"Zhou","year":"2018","journal-title":"Chem. Commun. (Camb)"},{"issue":"12","key":"2026072715541688200_cit256","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1021\/acs.biomac.0c01283","article-title":"Click Synthesis of Size- and Shape-Tunable Star Polymers with Functional\nMacrocyclic Cores for Synergistic DNA Complexation and Delivery","volume":"21","author":"Carbajo-Gordillo","year":"2020","journal-title":"Biomacromolecules"},{"issue":"65","key":"2026072715541688200_cit257","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202202020","article-title":"Using Macrocyclic G-Quadruplex Ligands to Decipher\nthe Interactions Between Small Molecules and G-Quadruplex DNA","volume":"28","author":"Andreasson","year":"2022","journal-title":"Chemistry"},{"issue":"7","key":"2026072715541688200_cit258","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1021\/acs.orglett.4c03727","article-title":"Stereoselective\nSynthesis\nof Benzoylated Gulmirecin A and Disciformycin B","volume":"27","author":"Ruhmann","year":"2025","journal-title":"Org. Lett."},{"issue":"35","key":"2026072715541688200_cit259","doi-asserted-by":"publisher","first-page":"14322","DOI":"10.1021\/jacs.1c06565","article-title":"Iodine-Mediated Tryptathionine\nFormation Facilitates\nthe Synthesis of Amanitins","volume":"143","author":"Yao","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"46","key":"2026072715541688200_cit260","doi-asserted-by":"publisher","first-page":"16903","DOI":"10.1021\/jacs.7b09635","article-title":"Cucurbit[7]uril-Driven\nHost-Guest Chemistry for Reversible Intervention of 5-Formylcytosine-Targeted\nBiochemical Reactions","volume":"139","author":"Wang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"2026072715541688200_cit261","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning\nfrom the Past: Possible Urgent Prevention and Treatment Options for\nSevere Acute Respiratory Infections Caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"Chembiochem"},{"key":"2026072715541688200_cit262","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115292","article-title":"Potential RNA-dependent\nRNA polymerase (RdRp) inhibitors as prospective drug candidates for\nSARS-CoV-2","volume":"252","author":"Bekheit","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"2026072715541688200_cit263","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131190","article-title":"In search\nof SARS CoV-2 replication inhibitors: Virtual screening, molecular\ndynamics simulations and ADMET analysis","volume":"1246","author":"Nagar","year":"2021","journal-title":"J.\nMol. Struct."},{"key":"2026072715541688200_cit264","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2021.07.050","article-title":"Repurposing nonnucleoside\nantivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase):\nIn silico-molecular insight","volume":"571","author":"Begum","year":"2021","journal-title":"Biochem. Biophys.\nRes. Commun."},{"issue":"1","key":"2026072715541688200_cit265","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s43556-021-00050-3","article-title":"Computationally\nrepurposed drugs and natural products against RNA dependent RNA polymerase\nas potential COVID-19 therapies","volume":"2","author":"Piplani","year":"2021","journal-title":"Mol. Biomed"},{"issue":"11","key":"2026072715541688200_cit266","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jiph.2022.09.007","article-title":"Repurposing of potential antiviral drugs against RNA-dependent RNA\npolymerase of SARS-CoV-2 by computational approach","volume":"15","author":"Gangadharan","year":"2022","journal-title":"J. Infect Public Health"},{"key":"2026072715541688200_cit267","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ijbiomac.2020.09.098","article-title":"Prediction\nof potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2\nusing comprehensive drug repurposing and molecular docking approach","volume":"163","author":"Parvez","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"13","key":"2026072715541688200_cit268","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jcc.26512","article-title":"Drug repositioning\nto target NSP15\nprotein on SARS-CoV-2 as possible COVID-19 treatment","volume":"42","author":"Sixto-Lopez","year":"2021","journal-title":"J. Comput. Chem."},{"issue":"5","key":"2026072715541688200_cit269","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1080\/07391102.2020.1839564","article-title":"Binding mechanism and structural\ninsights into the\nidentified protein target of COVID-19 and importin-alpha with in-vitro\neffective drug ivermectin","volume":"40","author":"Sen Gupta","year":"2022","journal-title":"J. Biomol Struct\nDyn"},{"issue":"7","key":"2026072715541688200_cit270","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010330","article-title":"Drug repurposing based\non a quantum-inspired\nmethod versus classical fingerprinting uncovers potential antivirals\nagainst SARS-CoV-2","volume":"18","author":"Jimenez-Guardeno","year":"2022","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"2026072715541688200_cit271","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C Virus Resistance to Direct-Acting Antiviral\nDrugs in Interferon-Free Regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"issue":"15","key":"2026072715541688200_cit272","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1016\/j.bmcl.2016.05.042","article-title":"Discovery of potent macrocyclic HCV NS5A inhibitors","volume":"26","author":"Yu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026072715541688200_cit273","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejmech.2015.07.046","article-title":"Recent advances\non\nthe synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase\ninhibitors","volume":"102","author":"Zhao","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"2026072715541688200_cit274","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114595","article-title":"Small molecule NS5B RdRp non-nucleoside\ninhibitors for the treatment of HCV infection: A medicinal chemistry\nperspective","volume":"240","author":"Zhou","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"2026072715541688200_cit275","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1002\/anie.201200110","article-title":"Structure-based\nmacrocyclization\nyields hepatitis C virus NS5B inhibitors with improved binding affinities\nand pharmacokinetic properties","volume":"51","author":"Cummings","year":"2012","journal-title":"Angew. Chem.,\nInt. Ed. Engl."},{"issue":"3","key":"2026072715541688200_cit276","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1021\/acs.jnatprod.2c00015","article-title":"Marine Natural Products as Leads\nagainst SARS-CoV-2 Infection","volume":"85","author":"Chhetri","year":"2022","journal-title":"J. Nat. Prod"},{"key":"2026072715541688200_cit277","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105923","article-title":"Identification of a\nmacrocyclic compound targeting the lassa virus polymerase","volume":"228","author":"Aida-Ficken","year":"2024","journal-title":"Antiviral Res."},{"issue":"4","key":"2026072715541688200_cit278","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1021\/acs.jmedchem.8b01529","article-title":"Discovery\nof Macrocyclic Inhibitors of Apurinic\/Apyrimidinic Endonuclease 1","volume":"62","author":"Trilles","year":"2019","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026072715541688200_cit279","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/med.21664","article-title":"Medicinal chemistry\nstrategies toward host targeting\nantiviral agents","volume":"40","author":"Ji","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"1","key":"2026072715541688200_cit280","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1038\/s41467-023-41442-z","article-title":"Proteomic and genetic analyses of influenza A viruses identify pan-viral\nhost targets","volume":"14","author":"Haas","year":"2023","journal-title":"Nat. Commun."},{"issue":"7816","key":"2026072715541688200_cit281","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2\nprotein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"2026072715541688200_cit282","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663586","article-title":"Repurposing\nIvermectin\nfor COVID-19: Molecular Aspects and Therapeutic Possibilities","volume":"12","author":"Wehbe","year":"2021","journal-title":"Front Immunol"},{"issue":"49","key":"2026072715541688200_cit283","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg4007","article-title":"De novo macrocyclic\npeptides for inhibiting, stabilizing, and probing the function of\nthe retromer endosomal trafficking complex","volume":"7","author":"Chen","year":"2021","journal-title":"Sci. Adv."},{"issue":"6","key":"2026072715541688200_cit284","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1021\/acs.jmedchem.3c02388","article-title":"Mechanism-Based\nMacrocyclic Inhibitors of Serine Proteases","volume":"67","author":"Damalanka","year":"2024","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026072715541688200_cit285","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/acsptsci.1c00078","article-title":"Physiologically\nBased Pharmacokinetic\/Pharmacodynamic Model for the Treatment of Dengue\nInfections Applied to the Broad Spectrum Antiviral Soraphen A","volume":"4","author":"Rox","year":"2021","journal-title":"ACS Pharmacol Transl Sci."},{"issue":"3","key":"2026072715541688200_cit286","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/acsinfecdis.5b00019","article-title":"Soraphen A: A Probe\nfor Investigating\nthe Role of de Novo Lipogenesis during Viral Infection","volume":"1","author":"Singaravelu","year":"2015","journal-title":"ACS Infect Dis"},{"issue":"1","key":"2026072715541688200_cit287","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.1038\/s41467-023-42417-w","article-title":"DNMT and HDAC inhibition\ninduces immunogenic neoantigens from human endogenous retroviral element-derived\ntranscripts","volume":"14","author":"Goyal","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"2026072715541688200_cit288","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.3892\/ol.2018.9468","article-title":"HDAC inhibitor apicidin suppresses\nmurine oral squamous\ncell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8\nexpression","volume":"16","author":"Ahn","year":"2018","journal-title":"Oncol Lett."},{"issue":"21","key":"2026072715541688200_cit289","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1002\/cncr.34974","article-title":"Recent\nhistone deacetylase inhibitors in cancer therapy","volume":"129","author":"Parveen","year":"2023","journal-title":"Cancer"},{"key":"2026072715541688200_cit290","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128168","article-title":"Discovery of macrocyclic HDACs 1, 2, and 3\nselective inhibitors for HIV latency reactivation","volume":"47","author":"Yu","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"2026072715541688200_cit291","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12985-023-02043-w","article-title":"Evaluating anti-viral effect of Tylvalosin\ntartrate\non porcine reproductive and respiratory syndrome virus and analyzing\nthe related gene regulation by transcriptomics","volume":"20","author":"Tang","year":"2023","journal-title":"Virol J."},{"issue":"1","key":"2026072715541688200_cit292","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/21505594.2021.2014680","article-title":"The battle for autophagy between\nhost and influenza A virus","volume":"13","author":"Zhou","year":"2022","journal-title":"Virulence"},{"issue":"7842","key":"2026072715541688200_cit293","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41586-020-03056-z","article-title":"Sorting nexin 5 mediates virus-induced autophagy and\nimmunity","volume":"589","author":"Dong","year":"2021","journal-title":"Nature"},{"key":"2026072715541688200_cit294","doi-asserted-by":"publisher","first-page":"1434775","DOI":"10.3389\/fcimb.2024.1434775","article-title":"Molecular\nmechanism\nof autophagy in porcine reproductive and respiratory syndrome virus\ninfection","volume":"14","author":"Chen","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2026072715541688200_cit295","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/21505594.2019.1605803","article-title":"The\nroles of apoptosis,\nautophagy and unfolded protein response in arbovirus, influenza virus,\nand HIV infections","volume":"10","author":"Mehrbod","year":"2019","journal-title":"Virulence"},{"issue":"4","key":"2026072715541688200_cit296","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1021\/acs.jmedchem.1c01973","article-title":"Isolation,\nSynthesis, and Structure-Activity Relationship Study on Daphnane and\nTigliane Diterpenes as HIV Latency-Reversing Agents","volume":"65","author":"El-Desoky","year":"2022","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026072715541688200_cit297","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1080\/15548627.2021.2015740","article-title":"2AB protein\nof Senecavirus A antagonizes selective\nautophagy and type I interferon production by degrading LC3 and MARCHF8","volume":"18","author":"Sun","year":"2022","journal-title":"Autophagy"},{"issue":"22","key":"2026072715541688200_cit298","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01575-20","article-title":"Mechanistic Target of Rapamycin Signaling\nActivation Antagonizes Autophagy To Facilitate Zika Virus Replication","volume":"94","author":"Sahoo","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"2026072715541688200_cit299","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2163","article-title":"Azithromycin\nin viral infections","volume":"31","author":"Oliver","year":"2021","journal-title":"Rev. Med. Virol"},{"issue":"4","key":"2026072715541688200_cit300","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jaci.2024.05.031","article-title":"Blockade of endolysosomal acidification suppresses\nTLR3-mediated proinflammatory signaling in airway epithelial cells","volume":"154","author":"Pejler","year":"2024","journal-title":"J. Allergy Clin Immunol"},{"issue":"21","key":"2026072715541688200_cit301","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s00018-018-2892-y","article-title":"The functional role\nof sodium taurocholate\ncotransporting polypeptide NTCP in the life cycle of hepatitis B,\nC and D viruses","volume":"75","author":"Eller","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"2026072715541688200_cit302","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/v12121458","article-title":"Resveratrol, Rapamycin and Metformin\nas Modulators of Antiviral Pathways","volume":"12","author":"Benedetti","year":"2020","journal-title":"Viruses"},{"key":"2026072715541688200_cit303","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116862","article-title":"Entry inhibition of hepatitis B virus using cyclosporin O derivatives\nwith peptoid side chain incorporation","volume":"68","author":"Lee","year":"2022","journal-title":"Bioorg.\nMed. Chem."},{"issue":"9","key":"2026072715541688200_cit304","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/v14092059","article-title":"Zika Virus\nExploits Lipid Rafts to Infect Host Cells","volume":"14","author":"Peruzzu","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"2026072715541688200_cit305","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1021\/acs.jnatprod.0c01243","article-title":"Antiviral Bafilomycins\nfrom a Feces-Inhabiting Streptomyces sp","volume":"84","author":"Xie","year":"2021","journal-title":"J.\nNat. Prod"},{"issue":"2","key":"2026072715541688200_cit306","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1476-5381.2011.01346.x","article-title":"The proton translocation domain of cellular vacuolar\nATPase provides a target for the treatment of influenza A virus infections","volume":"164","author":"Muller","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"2026072715541688200_cit307","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1038\/s41598-017-07023-z","article-title":"Blockade\nof dengue virus infection and viral cytotoxicity in neuronal cells\nin vitro and in vivo by targeting endocytic pathways","volume":"7","author":"Ho","year":"2017","journal-title":"Sci. Rep"},{"issue":"7","key":"2026072715541688200_cit308","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009706","article-title":"Strategies to target\nSARS-CoV-2 entry and infection using dual mechanisms of inhibition\nby acidification inhibitors","volume":"17","author":"Prabhakara","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"2026072715541688200_cit309","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/s41467-021-22126-y","article-title":"Quantitative characterization\nof extracellular vesicle uptake and content delivery within mammalian\ncells","volume":"12","author":"Bonsergent","year":"2021","journal-title":"Nat. Commun."},{"key":"2026072715541688200_cit310","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.ircmb.2020.09.003","article-title":"TAM receptors: A phosphatidylserine\nreceptor family\nand its implications in viral infections","volume":"357","author":"Ghosh Roy","year":"2020","journal-title":"Int.\nRev. Cell Mol. Biol."},{"issue":"12","key":"2026072715541688200_cit311","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1021\/acsmedchemlett.6b00221","article-title":"Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors","volume":"7","author":"Wang","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"7","key":"2026072715541688200_cit312","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/acs.jmedchem.4c00148","article-title":"Discovery\nof Novel Macrocyclic\nMERTK\/AXL Dual Inhibitors","volume":"67","author":"Kong","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026072715541688200_cit313","doi-asserted-by":"publisher","first-page":"12777","DOI":"10.1038\/ncomms12777","article-title":"Fragment-based discovery\nof a new family of non-peptidic small-molecule cyclophilin inhibitors\nwith potent antiviral activities","volume":"7","author":"Ahmed-Belkacem","year":"2016","journal-title":"Nat. Commun."},{"issue":"39","key":"2026072715541688200_cit314","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202201597","article-title":"Non-Immunosuppressive\ncyclophilin Inhibitors","volume":"61","author":"Schiene-Fischer","year":"2022","journal-title":"Angew. Chem., Int. Ed.\nEngl."},{"issue":"21","key":"2026072715541688200_cit315","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.1021\/acs.jmedchem.8b00802","article-title":"Discovery of a Potent and Orally Bioavailable\ncyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle","volume":"61","author":"Mackman","year":"2018","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026072715541688200_cit316","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/acs.jmedchem.6b01329","article-title":"Discovery\nof Potent cyclophilin Inhibitors Based on the Structural Simplification\nof Sanglifehrin A","volume":"60","author":"Steadman","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026072715541688200_cit317","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1021\/acs.orglett.3c04038","article-title":"Total Synthesis\nof carolacton and Demethylcarolactons\nwith Potent Antiviral Activity","volume":"26","author":"Zhang","year":"2024","journal-title":"Org. Lett."},{"key":"2026072715541688200_cit318","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.958634","article-title":"Effects of\nimmunophilin inhibitors and non-immunosuppressive analogs on coronavirus\nreplication in human infection models","volume":"12","author":"Berthold","year":"2022","journal-title":"Front\nCell Infect Microbiol"},{"issue":"7","key":"2026072715541688200_cit319","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00502-25","article-title":"Heat shock protein 90\nchaperone activity is required for hepatitis A virus replication","volume":"99","author":"Li","year":"2025","journal-title":"J. Virol."},{"issue":"1","key":"2026072715541688200_cit320","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-024-01874-5","article-title":"A Cullin 5-based complex\nserves as an essential modulator of ORF9b stability in SARS-CoV-2\nreplication","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2026072715541688200_cit321","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/ijms22042020","article-title":"Heat Shock Protein 90 Chaperones\nE1A Early Protein of Adenovirus 5 and Is Essential for Replication\nof the Virus","volume":"22","author":"Dalidowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026072715541688200_cit322","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1080\/22221751.2020.1850183","article-title":"Human coronavirus dependency\non host heat shock protein\n90 reveals an antiviral target","volume":"9","author":"Li","year":"2020","journal-title":"Emerg Microbes\nInfect"},{"issue":"20","key":"2026072715541688200_cit323","doi-asserted-by":"publisher","first-page":"17946","DOI":"10.1021\/acs.jmedchem.4c01048","article-title":"Geldanamycin, a Naturally Occurring Inhibitor of Hsp90\nand a Lead Compound for Medicinal Chemistry","volume":"67","author":"Kitson","year":"2024","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026072715541688200_cit324","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1021\/acs.jmedchem.9b00940","article-title":"Heat Shock Protein\n90 Inhibitors: An Update on Achievements, Challenges, and Future Directions","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"issue":"7","key":"2026072715541688200_cit325","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00135-21","article-title":"Radicicol\nInhibits Chikungunya Virus Replication by\nTargeting Nonstructural Protein 2","volume":"65","author":"Nam","year":"2021","journal-title":"Antimicrob.\nAgents Chemother."},{"key":"2026072715541688200_cit326","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03602532.2025.2542220","article-title":"Metabolism\nof new drug\nmodalities research advances-2024 year in review","author":"Ma","year":"2025","journal-title":"Drug Metab Rev."},{"issue":"15","key":"2026072715541688200_cit327","doi-asserted-by":"publisher","first-page":"15260","DOI":"10.1021\/acs.jmedchem.4c02886","article-title":"Macrocycles for Conventionally\nDruggable\nTargets: Lessons from Macrocyclic Kinase Inhibitors","volume":"68","author":"Viarengo-Baker","year":"2025","journal-title":"J. Med. Chem."},{"issue":"19","key":"2026072715541688200_cit328","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1016\/j.cell.2022.07.019","article-title":"Accurate de novo design\nof membrane-traversing macrocycles","volume":"185","author":"Bhardwaj","year":"2022","journal-title":"Cell"},{"issue":"7","key":"2026072715541688200_cit329","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1016\/j.apsb.2025.04.021","article-title":"Unraveling\nthe therapeutic\nlandscape of approved non-peptide macrocycles","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"4","key":"2026072715541688200_cit330","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.str.2018.02.011","article-title":"The Unusual Transmembrane Partition\nof the Hexameric Channel of the Hepatitis C Virus","volume":"26","author":"Chen","year":"2018","journal-title":"Structure"},{"key":"2026072715541688200_cit331","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.121403","article-title":"Spectral\nand theoretical study of SARS-CoV-2 ORF10 protein interaction with\nendogenous and exogenous macroheterocyclic compounds","volume":"279","author":"Koifman","year":"2022","journal-title":"Spectrochim Acta A Mol. Biomol Spectrosc"},{"issue":"1","key":"2026072715541688200_cit332","doi-asserted-by":"publisher","first-page":"19481","DOI":"10.1038\/s41598-021-99072-8","article-title":"Theoretical and\nexperimental study of interaction of macroheterocyclic compounds with\nORF3a of SARS-CoV-2","volume":"11","author":"Lebedeva","year":"2021","journal-title":"Sci. Rep"},{"key":"2026072715541688200_cit333","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.Virol.2021.11.008","article-title":"Pharmacologic\nprofiling reveals lapatinib as a novel antiviral against SARS-CoV-2\nin vitro","volume":"566","author":"Raymonda","year":"2022","journal-title":"Virology"},{"key":"2026072715541688200_cit334","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117373","article-title":"Synthesis and evolution\nof 16-membered macrolide carrimycin\nderivatives as a novel class of anti-HCoV-OC43 agents targeting viral\nFSE RNA","volume":"287","author":"Zhong","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"2026072715541688200_cit335","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07777","article-title":"Potential of diterpene compounds as antivirals, a review","volume":"7","author":"Wardana","year":"2021","journal-title":"heliyon"},{"issue":"10","key":"2026072715541688200_cit336","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1021\/acs.joc.0c00623","article-title":"Huperserratines\nA and B, Two Macrocyclic Lycopodium Alkaloids with an Unusual Skeleton\nfrom Huperzia serrata","volume":"85","author":"Wu","year":"2020","journal-title":"J. Org. Chem."},{"key":"2026072715541688200_cit337","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2023.113648","article-title":"Stelleratenoids A-F, macrocyclic Daphnane orthoesters\nwith anti-HIV activity from the roots of Stellera chamaejasme L","volume":"210","author":"Ding","year":"2023","journal-title":"Phytochemistry"},{"key":"2026072715541688200_cit338","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2023.105614","article-title":"Euphopias\nG - J, macrocyclic diterpenes with anti-zika\nvirus activity from Euphorbia helioscopia L","volume":"169","author":"Qiu","year":"2023","journal-title":"Fitoterapia"},{"issue":"9","key":"2026072715541688200_cit339","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107602","article-title":"Plant flavonoid\ninhibition of SARS-CoV-2 main protease and viral replication","volume":"26","author":"Lin","year":"2023","journal-title":"iScience"},{"key":"2026072715541688200_cit340","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-0716-1689-5_5","article-title":"Computational Design of Structured\nand Functional Peptide Macrocycles","volume":"2371","author":"Berger","year":"2022","journal-title":"Methods\nMol. Biol."},{"issue":"15","key":"2026072715541688200_cit341","doi-asserted-by":"publisher","first-page":"12146","DOI":"10.3390\/ijms241512146","article-title":"A Comprehensive\nTechnology Platform for the Rapid Discovery\nof Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection","volume":"24","author":"Beeg","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"2026072715541688200_cit342","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1039\/C6CC06951G","article-title":"A RaPID way to discover nonstandard\nmacrocyclic peptide modulators of drug targets","volume":"53","author":"Passioura","year":"2017","journal-title":"Chem. Commun. (Camb)"},{"issue":"7","key":"2026072715541688200_cit343","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1021\/acs.jcim.0c00132","article-title":"Evaluation of Free Energy Calculations\nfor the Prioritization of Macrocycle Synthesis","volume":"60","author":"Paulsen","year":"2020","journal-title":"J. Chem. Inf Model"},{"issue":"41","key":"2026072715541688200_cit344","doi-asserted-by":"publisher","first-page":"10852","DOI":"10.1073\/pnas.1710695114","article-title":"De novo design of\ncovalently constrained mesosize protein\nscaffolds with unique tertiary structures","volume":"114","author":"Dang","year":"2017","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02430","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/20\/21035\/66292097\/acs.jmedchem.5c02430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/20\/21035\/66292097\/acs.jmedchem.5c02430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:09:27Z","timestamp":1785182967000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/20\/21035\/5234646\/Macrocyclic-Compounds-Unveiling-Their-Distinctive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":344,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10,10]]},"published-print":{"date-parts":[[2025,10,23]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02430","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]}}}